Molecular Mechanisms of Green Tea Polyphenols

被引:62
作者
Dou, Q. Ping [1 ,2 ]
机构
[1] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Prevent Program, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2009年 / 61卷 / 06期
关键词
ENDOTHELIAL GROWTH-FACTOR; COLON-CARCINOMA CELLS; UBIQUITIN-PROTEASOME PATHWAY; KINASE INHIBITOR P27; (-)-EPIGALLOCATECHIN GALLATE; KAPPA-B; MULTIPLE-MYELOMA; BLACK TEA; EPIGALLOCATECHIN GALLATE; CANCER-CELLS;
D O I
10.1080/01635580903285049
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Tea, next to water, is the most popular beverage in the world. It has been suggested that tea consumption has the cancer-preventive effects. Epidemiological studies have indicated decreased cancer occurrence in people who regularly drink green tea. Research has also discovered numerous mechanisms of action to explain the biological effects of tea. The most abundant and popular compound studied in tea research is (-)-epigallocatechin-3-gallate or (-)- EGCG, which is a powerful antioxidant and can inhibit a number of tumor cell proliferation and survival pathways. Tea polyphenols are known to inhibit metaloproteonases, various protein kinases, and proteins that regulate DNA replication and transformation. We also reported that ester bond-containing tea polyphenols, for example, (-)- EGCG, potently and specifically inhibited the tumor proteasomal activity. We further demonstrated that methylation on green tea polyphenols under physiological conditions decreased their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption. Since (-)- EGCG is unstable under physiological conditions, we also developed the peracetate-protected or prodrug form of (-)EGCG, Pro-EGCG (1), and showed that Pro-EGCG (1) increases the bioavailability, stability, and proteasome-inhibitory and anticancer activities of (-)- EGCG in human breast cancer cells and tumors, demonstrating its potential use for cancer prevention and treatment.
引用
收藏
页码:827 / 835
页数:9
相关论文
共 108 条
[1]
Development of the proteasome inhibitor PS-341 [J].
Adams, J .
ONCOLOGIST, 2002, 7 (01) :9-16
[2]
Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate [J].
Ahmad, N ;
Cheng, PY ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :328-334
[3]
Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate [J].
Ahmad, N ;
Adhami, VM ;
Gupta, S ;
Cheng, PY ;
Mukhtar, H .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (01) :125-131
[4]
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells [J].
Ahmad, N ;
Feyes, DK ;
Nieminen, AL ;
Agarwal, R ;
Mukhtar, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) :1881-1886
[5]
Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172) [J].
Ahn, HY ;
Hadizadeh, KR ;
Seul, C ;
Yun, YP ;
Vetter, H ;
Sachinidis, A .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (04) :1093-1104
[6]
IDENTIFYING ENVIRONMENTAL CHEMICALS CAUSING MUTATIONS AND CANCER [J].
AMES, BN .
SCIENCE, 1979, 204 (4393) :587-593
[7]
Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts [J].
An, B ;
Goldfarb, RH ;
Siman, R ;
Dou, QP .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (12) :1062-1075
[8]
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[9]
Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells [J].
Berger, SJ ;
Gupta, S ;
Belfi, CA ;
Gosky, DM ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) :101-105
[10]
Birnboim HC, 1997, J CELL BIOCHEM, V66, P219, DOI 10.1002/(SICI)1097-4644(19970801)66:2<219::AID-JCB9>3.0.CO